Nonspecific amplification of human DNA by Streptococcus pneumoniae LytA primer

Helen Hencida Thangamony1, Ravindran Kumar1, Chinnappan Palaniappan Thangavelu1

  • 1Division of Molecular Diagnostics, Microbiological Laboratory, 12A Cowley Brown Road, R.S.Puram, Coimbatore, Tamil Nadu, India.

Abstract

Insights

High-resolution melt analysis (HRMA) for Streptococcus pneumoniae detection can show non-specific amplification of human DNA. Adjusting the cycle threshold resolved this issue, ensuring accurate results for meningitis diagnostics.

Area of Science:

  • Molecular Diagnostics
  • Microbiology

Background:

  • Primer validation is crucial for in-house nucleic acid amplification tests.
  • Standardizing high-resolution melt analysis (HRMA) for Streptococcus pneumoniae detection revealed non-specific human DNA amplification.

Purpose of the Study:

  • To standardize HRMA for Streptococcus pneumoniae detection.
  • To investigate and resolve non-specific amplification issues.

Main Methods:

  • HRMA was performed using S. pneumoniae DNA and specific primers.
  • Primer specificity was tested against various pathogens and human DNA.
  • Amplicon sequencing and Basic Local Alignment Search Tool (BLAST) analysis were conducted.

Main Results:

  • Non-specific amplification of human DNA sequences was observed.
  • BLAST analysis identified human chromosome 20 sequences.
  • Stopping the reaction at the 30th Ct cycle resolved the non-specific amplification.

Conclusions:

  • Awareness of potential non-specific amplification is essential when using HRMA with human clinical samples.
  • Primer selection and reaction optimization are critical for accurate diagnostic tests.

Related Concept Videos

DNA-only Transposons02:57

DNA-only Transposons

DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
17.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
925
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.0K
DNA Replication02:40

DNA Replication

DNA replication involves the separation of the two strands of the double helix, with each strand serving as a template from which the new complementary strand is copied.  After replication, each double-stranded DNA includes one parental or “old” strand and one “new” strand. This is known as semiconservative replication. The resulting DNA molecules have the same sequence and are divided equally into the two daughter cells.
Replication in Prokaryotes
DNA replication...
60.0K
Complementary DNA01:44

Complementary DNA

Overview
31.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
829